Perrigo Co. has received approval from the Food and Drug Administration for fluocinonide cream 0.1%, a topical steroid for skin inflammation and itching.


Perrigo, fluocinonide cream 0.1%, generic equivalent, Vanos Cream 0.1%, Medicis, Valeant Pharmaceuticals, topical steroid, corticosteroid, skin inflammation, skin conditions






































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Perrigo releases generic version of Vanos Cream

January 15th, 2014

DUBLIN, Ireland – Perrigo Co. has received approval from the Food and Drug Administration for fluocinonide cream 0.1%, a topical steroid for skin inflammation and itching.

The company said Tuesday that its has begun shipping the product, a generic equivalent to Vanos Cream 0.1%, from Medicis, a division of Valeant Pharmaceuticals.

Perrigo reported that it was awarded 180-days of generic drug exclusivity since it was the first company to submit an abbreviated new drug application (ANDA) containing a paragraph IV certification. Perrigo added that it previously resolved litigation with the brand.

A corticosteroid, Vanos Cream 0.1% is indicated for the treatment of inflammation and itching caused by such skin conditions as allergic reactions, eczema and psoriasis. The medication has estimated annual sales of about $107 million, according to Perrigo.

"This is another example of our Rx team's commitment to launching difficult-to-manufacture topicals, lotions and foams," stated Joseph Papa, Perrigo's chairman, president and chief executive officer.

Advertisement